{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T13:08:55Z","timestamp":1791378535117,"version":"4.3.2"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2005,6,12]],"date-time":"2005-06-12T00:00:00Z","timestamp":1118534400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2005,6,12]],"date-time":"2005-06-12T00:00:00Z","timestamp":1118534400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Med"],"published-print":{"date-parts":[[2005,7,1]]},"DOI":"10.1038\/nm1261","type":"journal-article","created":{"date-parts":[[2005,6,12]],"date-time":"2005-06-12T14:08:22Z","timestamp":1118585302000},"page":"740-747","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":414,"title":["Smallpox vaccine\u2013induced antibodies are necessary and sufficient for protection against monkeypox virus"],"prefix":"10.1038","volume":"11","author":[{"given":"Yvette","family":"Edghill-Smith","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hana","family":"Golding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jody","family":"Manischewitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa R","family":"King","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dorothy","family":"Scott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mike","family":"Bray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aysegul","family":"Nalca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jay W","family":"Hooper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chris A","family":"Whitehouse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joern E","family":"Schmitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keith A","family":"Reimann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Genoveffa","family":"Franchini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2005,6,12]]},"reference":[{"key":"BFnm1261_CR1","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1086\/381976","volume":"38","author":"M Bray","year":"2004","unstructured":"Bray, M. & Buller, M. Looking back at smallpox. Clin. Infect. Dis. 38, 882\u2013889 (2004).","journal-title":"Clin. Infect. Dis."},{"key":"BFnm1261_CR2","volume-title":"Smallpox and its eradication","author":"F Fenner","year":"1988","unstructured":"Fenner, F., Henderson, D.A., Arita, I., Jezek, Z. & Ladnyi, I. Smallpox and its eradication (World Health Organization, Geneva, 1988)."},{"key":"BFnm1261_CR3","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1086\/374244","volume":"36","author":"M Bray","year":"2003","unstructured":"Bray, M. & Wright, M.E. Progressive vaccinia. Clin. Infect. Dis. 36, 766\u2013774 (2003).","journal-title":"Clin. Infect. Dis."},{"key":"BFnm1261_CR4","first-page":"84","volume":"5","author":"AR Kemper","year":"2002","unstructured":"Kemper, A.R., Davis, M.M. & Freed, G.L. Expected adverse events in a mass smallpox vaccination campaign. Eff. Clin. Pract. 5, 84\u201390 (2002).","journal-title":"Eff. Clin. Pract."},{"key":"BFnm1261_CR5","doi-asserted-by":"publisher","first-page":"2127","DOI":"10.1001\/jama.281.22.2127","volume":"281","author":"DA Henderson","year":"1999","unstructured":"Henderson, D.A. et al. Smallpox as a biological weapon: medical and public health management. Working Group on Civilian Biodefense. J. Am. Med. Assoc. 281, 2127\u20132137 (1999).","journal-title":"J. Am. Med. Assoc."},{"key":"BFnm1261_CR6","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1038\/nature02331","volume":"428","author":"PL Earl","year":"2004","unstructured":"Earl, P.L. et al. Immunogenicity of a highly attenuated MVA smallpox vaccine and protection against monkeypox. Nature 428, 182\u2013185 (2004).","journal-title":"Nature"},{"key":"BFnm1261_CR7","doi-asserted-by":"publisher","first-page":"4433","DOI":"10.1128\/JVI.78.9.4433-4443.2004","volume":"78","author":"JW Hooper","year":"2004","unstructured":"Hooper, J.W. et al. Smallpox DNA vaccine protects nonhuman primates against lethal monkeypox. J. Virol. 78, 4433\u20134443 (2004).","journal-title":"J. Virol."},{"key":"BFnm1261_CR8","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.1038\/nm916","volume":"9","author":"R Weltzin","year":"2003","unstructured":"Weltzin, R. et al. Clonal vaccinia virus grown in cell culture as a new smallpox vaccine. Nat. Med. 9, 1125\u20131130 (2003).","journal-title":"Nat. Med."},{"key":"BFnm1261_CR9","doi-asserted-by":"publisher","first-page":"1581","DOI":"10.1038\/labinvest.3780373","volume":"81","author":"GM Zaucha","year":"2001","unstructured":"Zaucha, G.M., Jahrling, P.B., Geisbert, T.W., Swearengen, J.R. & Hensley, L. The pathology of experimental aerosolized monkeypox virus infection in cynomolgus monkeys (Macaca fascicularis). Lab. Invest. 81, 1581\u20131600 (2001).","journal-title":"Lab. Invest."},{"key":"BFnm1261_CR10","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1086\/378518","volume":"188","author":"Y Edghill-Smith","year":"2003","unstructured":"Edghill-Smith, Y. et al. Modeling a safer smallpox vaccination regimen, for human immunodeficiency virus type 1-infected patients, in immunocompromised macaques. J. Infect. Dis. 188, 1181\u20131191 (2003).","journal-title":"J. Infect. Dis."},{"key":"BFnm1261_CR11","doi-asserted-by":"publisher","first-page":"1923","DOI":"10.1016\/S0002-9440(10)65450-8","volume":"154","author":"JE Schmitz","year":"1999","unstructured":"Schmitz, J.E. et al. A nonhuman primate model for the selective elimination of CD8+ lymphocytes using a mouse-human chimeric monoclonal antibody. Am. J. Pathol. 154, 1923\u20131932 (1999).","journal-title":"Am. J. Pathol."},{"key":"BFnm1261_CR12","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1182\/blood.V83.2.435.435","volume":"83","author":"ME Reff","year":"1994","unstructured":"Reff, M.E. et al. Depletion of B cells in vivo by a chimeric mouse human monoclonal antibody to CD20. Blood 83, 435\u2013445 (1994).","journal-title":"Blood"},{"key":"BFnm1261_CR13","doi-asserted-by":"publisher","first-page":"2165","DOI":"10.1128\/JVI.77.3.2165-2173.2003","volume":"77","author":"JE Schmitz","year":"2003","unstructured":"Schmitz, J.E. et al. Effect of humoral immune responses on controlling viremia during primary infection of rhesus monkeys with simian immunodeficiency virus. J. Virol. 77, 2165\u20132173 (2003).","journal-title":"J. Virol."},{"key":"BFnm1261_CR14","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1086\/376557","volume":"188","author":"J Manischewitz","year":"2003","unstructured":"Manischewitz, J. et al. Development of a novel vaccinia-neutralization assay based on reporter-gene expression. J. Infect. Dis. 188, 440\u2013448 (2003).","journal-title":"J. Infect. Dis."},{"key":"BFnm1261_CR15","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1128\/JCM.42.2.601-609.2004","volume":"42","author":"DA Kulesh","year":"2004","unstructured":"Kulesh, D.A. et al. Smallpox and pan-orthopox virus detection by real-time 3\u2032-minor groove binder TaqMan assays on the Roche LightCycler and the Cepheid Smart Cycler platforms. J. Clin. Microbiol. 42, 601\u2013609 (2004).","journal-title":"J. Clin. Microbiol."},{"key":"BFnm1261_CR16","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1097\/00007890-199803150-00006","volume":"65","author":"GJ Mourad","year":"1998","unstructured":"Mourad, G.J. et al. Humanized IgG1 and IgG4 anti-CD4 monoclonal antibodies: effects on lymphocytes in the blood, lymph nodes, and renal allografts in cynomolgus monkeys. Transplantation 65, 632\u2013641 (1998).","journal-title":"Transplantation"},{"key":"BFnm1261_CR17","doi-asserted-by":"publisher","first-page":"214","DOI":"10.4269\/ajtmh.1972.21.214","volume":"21","author":"TM Mack","year":"1972","unstructured":"Mack, T.M., Noble, J., Jr & Thomas, D.B. A prospective study of serum antibody and protection against smallpox. Am. J. Trop. Med. Hyg. 21, 214\u2013218 (1972).","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"BFnm1261_CR18","first-page":"307","volume":"52","author":"JK Sarkar","year":"1975","unstructured":"Sarkar, J.K., Mitra, A.C. & Mukherjee, M.K. The minimum protective level of antibodies in smallpox. Bull. World Health Organ. 52, 307\u2013311 (1975).","journal-title":"Bull. World Health Organ."},{"key":"BFnm1261_CR19","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1086\/427265","volume":"191","author":"Y Edghill-Smith","year":"2005","unstructured":"Edghill-Smith, Y. et al. Smallpox vaccine does not protect macaques with AIDS from a lethal monkeypox virus challenge. J. Infect. Dis. 191, 372\u2013381 (2005).","journal-title":"J. Infect. Dis."},{"key":"BFnm1261_CR20","doi-asserted-by":"publisher","first-page":"4590","DOI":"10.1073\/pnas.0401165101","volume":"101","author":"LS Wyatt","year":"2004","unstructured":"Wyatt, L.S., Earl, P.L., Eller, L.A. & Moss, B. Highly attenuated smallpox vaccine protects mice with and without immune deficiencies against pathogenic vaccinia virus challenge. Proc. Natl Acad. Sci. USA 101, 4590\u20134595 (2004).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnm1261_CR21","doi-asserted-by":"publisher","first-page":"9458","DOI":"10.1073\/pnas.1233578100","volume":"100","author":"IM Belyakov","year":"2003","unstructured":"Belyakov, I.M. et al. Shared modes of protection against poxvirus infection by attenuated and conventional smallpox vaccine viruses. Proc. Natl Acad. Sci. USA 100, 9458\u20139463 (2003).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnm1261_CR22","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1126\/science.320661","volume":"195","author":"J Salk","year":"1977","unstructured":"Salk, J. & Salk, D. Control of influenza and poliomyelitis with killed virus vaccines. Science 195, 834\u2013847 (1977).","journal-title":"Science"},{"key":"BFnm1261_CR23","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.1128\/jvi.66.3.1610-1621.1992","volume":"66","author":"SA Duncan","year":"1992","unstructured":"Duncan, S.A. & Smith, G.L. Identification and characterization of an extracellular envelope glycoprotein affecting vaccinia virus egress. J. Virol. 66, 1610\u20131621 (1992).","journal-title":"J. Virol."},{"key":"BFnm1261_CR24","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1016\/0042-6822(92)90535-W","volume":"188","author":"M Engelstad","year":"1992","unstructured":"Engelstad, M., Howard, S.T. & Smith, G.L. A constitutively expressed vaccinia gene encodes a 42-kDa glycoprotein related to complement control factors that forms part of the extracellular virus envelope. Virology 188, 801\u2013810 (1992).","journal-title":"Virology"},{"key":"BFnm1261_CR25","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1128\/jvi.58.3.757-764.1986","volume":"58","author":"P Hirt","year":"1986","unstructured":"Hirt, P., Hiller, G. & Wittek, R. Localization and fine structure of a vaccinia virus gene encoding an envelope antigen. J. Virol. 58, 757\u2013764 (1986).","journal-title":"J. Virol."},{"key":"BFnm1261_CR26","doi-asserted-by":"crossref","first-page":"7217","DOI":"10.1128\/jvi.66.12.7217-7224.1992","volume":"66","author":"SN Isaacs","year":"1992","unstructured":"Isaacs, S.N., Wolffe, E.J., Payne, L.G. & Moss, B. Characterization of a vaccinia virus-encoded 42-kilodalton class I membrane glycoprotein component of the extracellular virus envelope. J. Virol. 66, 7217\u20137224 (1992).","journal-title":"J. Virol."},{"key":"BFnm1261_CR27","doi-asserted-by":"crossref","first-page":"3753","DOI":"10.1128\/jvi.70.6.3753-3762.1996","volume":"70","author":"RL Roper","year":"1996","unstructured":"Roper, R.L., Payne, L.G. & Moss, B. Extracellular vaccinia virus envelope glycoprotein encoded by the A33R gene. J. Virol. 70, 3753\u20133762 (1996).","journal-title":"J. Virol."},{"key":"BFnm1261_CR28","unstructured":"Centers for Disease Control and Prevention. Multistate outbreak of monkeypox\u2013Illinois, Indiana, and Wisconsin, 2003. Morb. Mortal. Wkly. Rep. 52, 537\u2013540 (2003)."},{"key":"BFnm1261_CR29","unstructured":"Centers for Disease Control and Prevention. Update: multistate outbreak of monkeypox\u2013Illinois, Indiana, Kansas, Missouri, Ohio, and Wisconsin, 2003. Morb. Mortal. Wkly. Rep. 52, 642\u2013646 (2003)."},{"key":"BFnm1261_CR30","first-page":"613","volume":"55","author":"ID Ladnyi","year":"1972","unstructured":"Ladnyi, I.D., Ziegler, P. & Kima, E. A human infection caused by monkey pox virus in Basankusu Territory, Democratic Republic of the Congo. Bull. World Health Organ. 55, 613\u2013623 (1972).","journal-title":"Bull. World Health Organ."},{"key":"BFnm1261_CR31","first-page":"246","volume":"33","author":"SS Marennikova","year":"1989","unstructured":"Marennikova, S.S. et al. Monkey pox in humans: current results. Acta Virol. 33, 246\u2013253 (1989).","journal-title":"Acta Virol."},{"key":"BFnm1261_CR32","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/0042-6822(92)90752-B","volume":"188","author":"J Tartaglia","year":"1992","unstructured":"Tartaglia, J. et al. NYVAC: a highly attenuated strain of vaccinia virus. Virology 188, 217\u2013232 (1992).","journal-title":"Virology"},{"key":"BFnm1261_CR33","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1007\/978-1-4899-1382-1_2","volume":"397","author":"B Moss","year":"1996","unstructured":"Moss, B. et al. Host range restricted, non-replicating vaccinia virus vectors as vaccine candidates. Adv. Exp. Med. Biol. 397, 7\u201313 (1996).","journal-title":"Adv. Exp. Med. Biol."},{"key":"BFnm1261_CR34","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/S0042-6822(02)00038-7","volume":"306","author":"JW Hooper","year":"2003","unstructured":"Hooper, J.W., Custer, D.M. & Thompson, E. Four-gene-combination DNA vaccine protects mice against a lethal vaccinia virus challenge and elicits appropriate antibody responses in nonhuman primates. Virology 306, 181\u2013195 (2003).","journal-title":"Virology"},{"key":"BFnm1261_CR35","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.2144\/97236st07","volume":"23","author":"S Chakrabarti","year":"1997","unstructured":"Chakrabarti, S., Sisler, J.R. & Moss, B. Compact, synthetic, vaccinia virus early\/late promoter for protein expression. Biotechniques 23, 1094\u20131097 (1997).","journal-title":"Biotechniques"}],"container-title":["Nature Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/nm1261.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/nm1261","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/nm1261.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,23]],"date-time":"2023-05-23T13:48:15Z","timestamp":1684849695000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/nm1261"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,6,12]]},"references-count":35,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2005,7,1]]}},"alternative-id":["BFnm1261"],"URL":"https:\/\/doi.org\/10.1038\/nm1261","relation":{},"ISSN":["1078-8956","1546-170X"],"issn-type":[{"value":"1078-8956","type":"print"},{"value":"1546-170X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,6,12]]},"assertion":[{"value":"8 April 2005","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 May 2005","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 June 2005","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing financial interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}